Chemotherapy delivery issues in central nervous system malignancy: a reality check.
about
Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancerMagnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapyCell-surface central nervous system autoantibodies: clinical relevance and emerging paradigmsBeyond high-dose methotrexate and brain radiotherapy: novel targets and agents for primary CNS lymphomaInduction of selective blood-tumor barrier permeability and macromolecular transport by a biostable kinin B1 receptor agonist in a glioma rat modelStructural Insights into the Pharmacophore of Vinca Domain Inhibitors of MicrotubulesGlucocorticoids in the management of peritumoral brain edema: a review of molecular mechanismsEnhancing drug delivery for boron neutron capture therapy of brain tumors with focused ultrasoundEnhancing the efficacy of drug-loaded nanocarriers against brain tumors by targeted radiation therapy.Contrast-enhanced in vivo magnetic resonance microscopy of the mouse brain enabled by noninvasive opening of the blood-brain barrier with ultrasound.Magnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brain.Non-invasive quantification of brain tumor-induced astrogliosis.Delivery of chemotherapeutics across the blood-brain barrier: challenges and advances.Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats.Intra-arterial chemotherapy with osmotic blood-brain barrier disruption for aggressive oligodendroglial tumors: results of a phase I study.Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma.Effect of blood brain barrier permeability in recurrent high grade gliomas on the intratumoral pharmacokinetics of methotrexate: a microdialysis studyPatterns of relapse in primary central nervous system lymphoma: inferences regarding the role of the neuro-vascular unit and monoclonal antibodies in treating occult CNS disease.Progress on antiangiogenic therapy for patients with malignant glioma.Atypical Teratoid Rhabdoid Tumor: Two Case Reports and an Analysis of Adult Cases with Implications for Pathophysiology and Treatment.Tumor-associated macrophages are predominant carriers of cyclodextrin-based nanoparticles into gliomas.Tissue concentration of systemically administered antineoplastic agents in human brain tumors.Approaches for optimal drug development and clinical trial design for breast cancer brain metastasis.Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner.A review of current management of brain metastases.Imaging of convection enhanced delivery of toxins in humans.Medical therapy of gliomas.Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer.Pharmacokinetics and efficacy of PEGylated liposomal doxorubicin in an intracranial model of breast cancer.A robust approach to enhance tumor-selective accumulation of nanoparticles.S100B attenuates microglia activation in gliomas: possible role of STAT3 pathwayPlasmonics-enhanced and optically modulated delivery of gold nanostars into brain tumor.Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.Sorafenib exerts anti-glioma activity in vitro and in vivo.Effective Treatment of Established GL261 Murine Gliomas through Picornavirus Vaccination-Enhanced Tumor Antigen-Specific CD8+ T Cell Responses.Overcoming the challenges in the effective delivery of chemotherapies to CNS solid tumors.Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1.Evolution of multidisciplinary brain metastasis management: case study and literature reviewThe biology of brain metastases-translation to new therapies
P2860
Q24621947-815B9E7C-CB57-451A-9B2B-7297C496492AQ27004205-AD235A3F-3ABE-45D8-9F22-E99E0E275D4CQ27006941-F91E1CED-DCCF-444F-8DB3-7708B164FADFQ27013785-E34920FD-F834-43BE-974B-E272457F353CQ27302402-8F196555-8BE5-4C10-A582-4D0C8A5347F8Q27703132-0864B304-F4D1-4C91-8678-613497CEADB9Q28075735-0410116C-A2A5-447F-A3A7-BE88BE849B1EQ30432022-A9B81584-F30B-4384-A4DD-AAB0FAF48845Q30452421-FED0D3E0-0AC7-4E9D-A7B0-CEF03653A3C7Q30474000-1D8BC60A-BE4B-4AEA-AA4D-BA888D804B94Q30479578-C2C92AC0-1FB1-471C-B387-531DDFEAD69BQ30498097-48DBFB0A-2ED8-4F5F-BE67-FD482ED11719Q30859319-7AE3F673-A3E9-48D2-BF59-6104EC1D36F5Q31106992-24A4EB24-ED19-417F-ADC1-980F3F30FD4FQ33387577-FEE77A26-2FC9-4002-9ACC-FE212AA1C571Q33518926-952E59D1-5AB0-4DA6-9B4E-73B3F525A9AAQ33626490-8F03AF52-8A50-4786-BD96-0F3F992CB78BQ33642314-F00033E2-EC5E-4FDC-8F09-96B2823D8832Q33759799-B34DE146-9068-48AC-A803-FEB4E20821B2Q33773189-DC80C2F1-2ED6-4701-A9D5-229EE18DACA4Q33814037-691BC768-CFD9-416C-A77D-7265ED0B266DQ33837621-0497D67D-6F4C-4460-8029-EA645812730AQ33844823-F593F661-2F42-4FE5-8E67-207F6ACE743DQ33891408-435B50FF-F131-4B7B-A8C4-097FA18AADD5Q33909294-F0BCB35A-6B5F-4399-827D-C5B5EC1800F2Q34000987-410E9186-01CB-42B4-84D3-1ADB7DD9DDF3Q34070650-46622854-E317-49D5-A01F-56153845B6DCQ34218761-F1E7E18E-4890-4C9E-AFF5-7B4D3ACCDAE2Q34393640-EA3F3746-5C35-460E-A33A-4E3E9008EFFBQ34708283-C0300838-999C-4655-95FC-C7B0CA132263Q34754720-86ADEF7B-F0DC-47FF-8B93-B59098C6D9A7Q34821218-EC6F662D-552C-4003-BA45-8760CD50B468Q35118176-6C34BEEF-59D3-41CD-A619-DD2A429ED51EQ35179525-7F254592-E9F7-4417-A895-9771791D45A8Q35414966-03DBEF32-EB80-4D19-8266-70680403A3A3Q35561280-40466ACB-6CC1-4F50-B09A-D47CAA558064Q35602796-2E112AB8-DD2C-49DA-B121-23D5721388CFQ35623290-8A31B6CE-F517-4D50-9CF8-8E561C2FB5B4Q35652704-B0519BEF-958F-493B-A041-35BC6A643252Q35676602-7C1CDE99-3B74-4AF0-9738-BB075B85EB59
P2860
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
@en
type
label
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
@en
prefLabel
Chemotherapy delivery issues in central nervous system malignancy: a reality check.
@en
P2093
P50
P356
P1476
Chemotherapy delivery issues in central nervous system malignancy: a reality check
@en
P2093
Carole Soussain
David M Peereboom
Kristoph Jahnke
Leslie L Muldoon
Peter D Senter
Quentin R Smith
Tali Siegal
Walter A Hall
P304
P356
10.1200/JCO.2006.09.9861
P407
P577
2007-06-01T00:00:00Z